{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:07:38Z","timestamp":1760144858673,"version":"build-2065373602"},"reference-count":86,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Dimitrios P [...]<\/jats:p>","DOI":"10.3390\/jof10060382","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:33:31Z","timestamp":1716802411000},"page":"382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-4339","authenticated-orcid":false,"given":"Russell E.","family":"Lewis","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, University of Padua, 35121 Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"ref_1","unstructured":"Aria, M. (2024, May 15). PubmedR: Gathering Metadata about Publications, Grants, Clinical Trials from \u2018PubMed\u2019 Database. Available online: https:\/\/github.com\/massimoaria\/pubmedR."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: An r-Tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Informetr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp074","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: The early years","volume":"63","author":"Bodey","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0021-9681(66)90066-X","article-title":"Fungal infections complicating acute leukemia","volume":"19","author":"Bodey","year":"1966","journal-title":"J. Chron. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: Systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/clinids\/18.6.925","article-title":"Infections due to Cunninghamella bertholletiae in patients with cancer: Report of three cases and review","volume":"18","author":"Kontoyianis","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/clinids\/17.6.1022","article-title":"Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: Experience with SCH 39304","volume":"17","author":"Anaissie","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.43.11.2731","article-title":"Genetic Analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae","volume":"43","author":"Kontoyiannis","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000007262","article-title":"Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae","volume":"46","author":"Kontoyiannis","year":"2000","journal-title":"Chemotherapy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/AAC.43.11.2798","article-title":"Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae","volume":"43","author":"Kontoyiannis","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/AAC.46.4.1153-1155.2002","article-title":"Lack of Catheter Infection by the Efg1\/Efg1 Cph1\/Cph1 Double-Null Mutant, a Candida albicans strain that is defective in filamentous growth","volume":"46","author":"Lewis","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/ciy181","article-title":"Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009\u20132013","volume":"67","author":"Zilberberg","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A Case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_19","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-Year period (1989\u20132003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/dkn224","article-title":"Does Pre-Exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis","volume":"62","author":"Lamaris","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/597615","article-title":"Increased virulence of zygomycetes organisms following exposure to voriconazole: A study involving fly and murine models of zygomycosis","volume":"199","author":"Lamaris","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4161\/viru.2.4.17074","article-title":"Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection","volume":"2","author":"Lewis","year":"2011","journal-title":"Virulence"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wurster, S., Lewis, R.E., Albert, N.D., and Kontoyiannis, D.P. (2019). Preexposure to isavuconazole increases the virulence of Mucorales but not Aspergillus fumigatus in a Drosophila melanogaster infection model. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.01896-18"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1128\/AAC.01583-15","article-title":"Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae","volume":"59","author":"Bellanger","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Axell-House, D.B., Wurster, S., Jiang, Y., Kyvernitakis, A., Lewis, R.E., Tarrand, J.J., Raad, I.I., and Kontoyiannis, D.P. (2021). Breakthrough mucormycosis developing on Mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer. J. Fungi, 7.","DOI":"10.3390\/jof7030217"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of Zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/myc.12149","article-title":"Prospective Antifungal Therapy (PATH) Alliance\u00ae: Focus on mucormycosis","volume":"57","author":"Kontoyiannis","year":"2013","journal-title":"Mycoses"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Franklin, A., Wurster, S., Axell-House, D.B., Jiang, Y., and Kontoyiannis, D.P. (2022). Impact of hyperglycemia and diabetes mellitus on breakthrough mucormycosis outcomes in patients with hematologic malignancies complex and intriguing associations. J. Fungi, 9.","DOI":"10.3390\/jof9010045"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gamaletsou, M.N., Rammaert, B., Brause, B., Bueno, M.A., Dadwal, S.S., Henry, M.W., Katragkou, A., Kontoyiannis, D.P., McCarthy, M.W., and Miller, A.O. (2022). Osteoarticular mycoses. Clin. Micro Rev., 35.","DOI":"10.1128\/cmr.00086-19"},{"key":"ref_31","first-page":"691","article-title":"Bone and joint infections caused by Mucormycetes: A challenging osteoarticular mycosis of the twenty-first century","volume":"55","author":"Gamaletsou","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_32","first-page":"661","article-title":"Gastrointestinal mucormycosis: An elusive, unusual, and severe opportunistic mycosis","volume":"5","author":"Adachi","year":"2009","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMra1216008","article-title":"Mold infections of the central nervous system","volume":"371","author":"McCarthy","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chikley, A., Ben-Ami, R., and Kontoyiannis, D.P. (2019). Mucormycosis of the central nervous system. J. Fungi, 5.","DOI":"10.3390\/jof5030059"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jinf.2022.03.009","article-title":"Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey\u2014A closer look at an immunocompromised cancer patient population","volume":"84","author":"Wurster","year":"2022","journal-title":"J. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/eci.12467","article-title":"Healthcare-associated outbreaks due to Mucorales and other uncommon fungi","volume":"45","author":"Davoudi","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"ofz385","DOI":"10.1093\/ofid\/ofz385","article-title":"Insect bite associated invasive fungal infections","volume":"6","author":"Kontoyiannis","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Walsh, T.J., Hospenthal, D.R., Petraitis, V., and Kontoyiannis, D.P. (2019). Necrotizing mucormycosis of wounds following combat injuries, natural disasters, burns, and other trauma. J. Fungi, 5.","DOI":"10.3390\/jof5030057"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/myc.13578","article-title":"Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors","volume":"66","author":"Chowdhary","year":"2023","journal-title":"Mycoses"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"John, T.M., Jacob, C.N., and Konotyiannis, D.P. (2021). When uncontrolled diabetes mellitus and severe COVID-19 converge: The perfect storm for mucormycosis. J. Fungi, 7.","DOI":"10.3390\/jof7040298"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Skaria, J., John, T.M., Varkey, S., and Kontoyiannis, D.P. (2022). Are Unique regional factors the missing link in India\u2019s COVID-19-associated Mucormycosis crisis?. mBio, 13.","DOI":"10.1128\/mbio.00473-22"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kontoyiannis, D.P., Yang, H., Song, J., Kelkar, S.S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., and Spalding, J.R. (2016). Prevalence, clinical and economic burden of Mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-2023-z"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/587991","article-title":"Reversed halo sign in invasive pulmonary fungal infections","volume":"46","author":"Wahba","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin b-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have Zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/7KU5XWURYM0151YN","article-title":"Increased culture recovery of Zygomycetes under physiologic temperature conditions","volume":"127","author":"Kontoyiannis","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Spallone, A., Moran, C.A., Wurster, S., Axell-House, D.B., and Kontoyiannis, D.P. (2022). Taking a Closer Look: Clinical and histopathological characteristics of culture-positive versus culture-negative pulmonary mucormycosis. J. Fungi, 8.","DOI":"10.20944\/preprints202203.0162.v1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/JCM.00917-08","article-title":"Detection of a molecular biomarker for Zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis","volume":"46","author":"Kasai","year":"2008","journal-title":"J. Clin. Micrbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14737159.2024.2326474","article-title":"PCR Diagnostic platforms for Non-Aspergillus mold infections: Ready for routine implementation in the clinic?","volume":"24","author":"Lamoth","year":"2024","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Shelburne, S.A., Ajami, N.J., Chibucos, M.C., Beird, H.C., Tarrand, J., Galloway-Pe\u00f1a, J., Albert, N., Chemaly, R.F., Ghantoji, S.S., and Marsh, L. (2015). Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: A case report of a leukemic patient with invasive mucormycosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139851"},{"key":"ref_54","first-page":"159","article-title":"Pulmonary mucormycosis in rabbits with alloxan diabetes; Increased invasiveness of fungus during acute toxic phase of diabetes","volume":"61","author":"Elder","year":"1956","journal-title":"A.M.A. Arch. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.01222-09","article-title":"Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/AAC.01812-10","article-title":"Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis","volume":"55","author":"Lewis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/589305","article-title":"Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae","volume":"198","author":"Lamaris","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1128\/AAC.03569-14","article-title":"Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis","volume":"58","author":"Lewis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/infdis\/jis767","article-title":"Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus Oryzae in Vitro and in an Experimental Model of Mucormycosis","volume":"207","author":"Lewis","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.00956-09","article-title":"Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Barbu, E.M., Shirazi, F., McGrath, D.M., Albert, N., Sidman, R.L., Pasqualini, R., Arap, W., and Kontoyiannis, D.P. (2013). An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076981"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","article-title":"The Dorsoventral regulatory gene Ccssette Sp\u00e4tzle\/Toll\/Cactus controls the potent antifungal response in Drosophila adults","volume":"86","author":"Lemaitre","year":"1996","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/428587","article-title":"Toll-Deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence","volume":"191","author":"Lionakis","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.0709578105","article-title":"Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis","volume":"105","author":"Chamilos","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through Toll-Like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00994-09","article-title":"Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis","volume":"53","author":"Pongas","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Shirazi, F., Farmakiotis, D., Yan, Y., Albert, N., Kim-Anh, D., and Kontoyiannis, D.P. (2014). Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108635"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Wurster, S., Tatara, A.M., Albert, N.D., Ibrahim, A.S., Heitman, J., Lee, S.C., Shetty, A.C., McCracken, C., Graf, K.T., and Mikos, A.G. (2020). Tornadic shear stress induces a transient, calcineurin-dependent hypervirulent phenotype in Mucorales molds. mBio, 11.","DOI":"10.1128\/mBio.01414-20"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin concentrations below the minimum inhibitory concentration attenuate the virulence of Rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.xpro.2021.100963","article-title":"Protocol for fungal infection following the induction of epithelial cell loss in larval zebrafish","volume":"2","author":"Wurster","year":"2021","journal-title":"STAR Protoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"108896","DOI":"10.1016\/j.celrep.2021.108896","article-title":"EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion","volume":"34","author":"Wurster","year":"2021","journal-title":"Cell Rep."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Egge, S.L., Wurster, S., Cho, S.Y., Jiang, Y., Axell-House, D.B., Miller, W.R., and Kontoyiannis, D.P. (2024). Co-occurrence of gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis. J. Fungi, 10.","DOI":"10.3390\/jof10010041"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases","volume":"42","author":"Hare","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/myc.13412","article-title":"Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (Non-fumigatus): A multicentre, non-interventional registry study","volume":"65","author":"Thompson","year":"2021","journal-title":"Mycoses"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: A propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox-AmBisome therapy for mucormycosis (DEFEAT Mucor) Study: A randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"John","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QCO.0000000000000277","article-title":"Treatment of mucormycosis in transplant patients: Role of surgery and of old and new antifungal agents","volume":"29","author":"Chitasombat","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/cid\/ciz1195","article-title":"How long do we need to treat an invasive mold disease in hematology Patients? Factors influencing duration of therapy and future questions","volume":"71","author":"Lewis","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11046-014-9785-x","article-title":"A Long-term survivor of disseminated Aspergillus and Mucorales infection: An instructive case","volume":"178","author":"Davoudi","year":"2014","journal-title":"Mycopathologia"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/myc.13120","article-title":"Non-Aspergillus invasive mould infections in patients treated with ibrutinib","volume":"63","author":"Anastasopoulou","year":"2020","journal-title":"Mycoses"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S1470-2045(17)30852-5","article-title":"Checkpoint inhibitors and aspergillosis in AML: The double hit hypothesis","volume":"18","author":"Daver","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1018202","DOI":"10.3389\/fimmu.2022.1018202","article-title":"Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions","volume":"13","author":"Wurster","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"838344","DOI":"10.3389\/fimmu.2022.838344","article-title":"Blockade of the PD-1\/PD-L1 immune checkpoint pathway improves infection outcomes and enhances fungicidal host defense in a murine model of invasive pulmonary mucormycosis","volume":"13","author":"Wurster","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.omtm.2018.03.003","article-title":"A new method for reactivating and expanding T cells specific for Rhizopus oryzae","volume":"9","author":"Castillo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/6\/382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:49:22Z","timestamp":1760107762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/6\/382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":86,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["jof10060382"],"URL":"https:\/\/doi.org\/10.3390\/jof10060382","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}